Browsing by Author El-Hoss, Jad

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2011Assessment of Tumor Prevention in Type 1 Neurofibromatosis using a Nitroxide CompoundEl-Hoss, Jad; Little, David; Schindeler, Aaron; Bottle, Steven; Fairfull-Smith, Kathryn; Micallef, Aaron S; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child HealthAssessment of Tumor Prevention in Type 1 Neurofibromatosis using a Nitroxide Compound, Free Radicals and Antioxidants, vol.1, 3, 2011,pp 13-18
2014A combination of rhBMP-2 (recombinant human Bone Morphogenetic Protein-2) and MEK (MAP kinase/ERK kinase) inhibitor PD0325901 increases bone formation in a murine model of neurofibromatosis type I pseudarthrosisLittle, David; Schindeler, Aaron; Carpenter, Eleanor; Cheng, Tegan; Deo, N; El-Hoss, Jad; Mikulec, Kathy; Sullivan, K; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child HealthA combination of rhBMP-2 (recombinant human Bone Morphogenetic Protein-2) and MEK (MAP kinase/ERK kinase) inhibitor PD0325901 increases bone formation in a murine model of neurofibromatosis type I pseudarthrosis, Journal of Bone and Joint Surgery: American Volume, vol.96, 14, 2014,pp 1-11
2011JNK inhibitors increase osteogenesis in Nf1-deficient cellsLittle, David; Schindeler, Aaron; Sullivan, Kate; El-Hoss, Jad; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child HealthJNK inhibitors increase osteogenesis in Nf1-deficient cells, Bone, vol.49, 6, 2011,pp 1311-1316
2014Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib)Deo, Nikita; El-Hoss, Jad; Jackson, Miriam; Little, Christopher; Little, David; Schindeler, Aaron; Kolind, Mille; McDonald, Michelle; Mikulec, Kathy; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child HealthModulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib), Bone, vol.59, N/A, 2014,pp 151-161
2012A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cellsAlexander, Ian; Bobyn, Justin; El-Hoss, Jad; Little, David; Schindeler, Aaron; Sullivan, Kate; Baldock, Paul A.; Cheng, Tegan; Mikulec, Kathy; Peacock, Lauren; Yu, Nicole; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child HealthA murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells, Journal of Bone and Mineral Research, vol.27, 1, 2012,pp 68-78
2014NF1 is a critical regulator of muscle development and metabolismDeo, Nikita; El-Hoss, Jad; Garton, Fleur; Little, David; North, Kathryn; Quinlan (nee Edwards), Kate Gemma; Schindeler, Aaron; Seto, Jane Tin Chi; Cooney, Gregory; Gdalevitch, Marie; Kolanczyk, Mateusz; Sullivan, K; Turner, Nigel; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child Health; Western Clinical School: Medicine (Westmead); Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Paediatrics & Child HealthNF1 is a critical regulator of muscle development and metabolism, Human Molecular Genetics, vol.23, 5, 2014,pp 1250-1259